Not finding it? Sign in to also search OpenAlex live.
-
Effect of hydroxychloroquine on the cardiac ventricular repolarization: A randomized clinical trial2021 British Journal of Clinical Pharmacology article Medicine Cardiac electrophysiology and arrhythmias Open access
Boukje C. Eveleens Maarse, Claus Graff, Jørgen Kim Kanters, Michiel Joost van Esdonk, Michiel J. B. Kemme, Aliede E. in ‘t Veld, +3 more
9citations -
Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949134citations
-
Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”2020 International Journal of Infectious Diseases article Medicine COVID-19 Clinical Research Studies Open access
Marijke Linschoten, Linda Nab, Iwan C.C. van der Horst, Robert G Tieleman, Folkert Wouter Asselbergs
11citations -
Bias in observational studies on the effectiveness of in hospital use of hydroxychloroquine in COVID ‐192023 Pharmacoepidemiology and Drug Safety article Medicine COVID-19 Clinical Research Studies Open access
Mirjam Hempenius, Sophie H. Bots, Rolf H. H. Groenwold, Anthonius de Boer, Olaf H. Klungel, Helga Gardarsdóttir
4citations -
Hydroxychloroquine en chloroquine bij COVID-19.Geen bewijs voor effectiviteit2020 Rivm (National Institute for Public Health and the Environment) article Medicine COVID-19 Clinical Research Studies Open access
Albert M. Vollaard, Emilie M. Gieling, Paul van der Linden, Bhanu N. M. Sinha, Mark G. J. de Boer
0citations -
Real-world Evidence of the Effects of Novel Treatments for COVID-19 on Mortality: A Nationwide Comparative Cohort Study of Hospitalized Patients in the First, Second, Third, and Fourth Waves in the Netherlands
Marleen A. Slim, Brent Appelman, Hessel Peters Sengers, Dave Anton Dongelmans, Nicolette F. de Keizer, Rogier P. Schade, +21 more
13citations -
POS0775 RITUXIMAB ASSOCIATED WITH A DECREASED RISK OF LUPUS NEPHRITIS FLARE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Lupus Erythematosus Research Open access
T.J. Lee, Ting‐Yuan Lan, I. Parodis, Cheng‐Hsien Lu, Chen‐Yang Shen, Kejun Li, +1 more
1citations -
Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis – A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria
Kristina Vollbach, Catharina Schuetz, Christian Michael Hedrich, Fabian Speth, Kirsten Mönkemöller, Jürgen Brunner, +15 more
8citations -
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis2026 Annals of the Rheumatic Diseases review Medicine Rheumatoid Arthritis Research and Therapies Open access
Victoria Konzett, Faidra Laskou, Josef S Smolen, Christopher J. Edwards, Daniel Aletaha, Désirée M F M van der Heijde, +12 more
5citations -
PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach
Hamit Harun Dağ, Agnes E M Looijen, Harald E. Vonkeman, Annemiek Willemze, Lindy‐Anne Korswagen, Roos C Padmos, +8 more
2citations -
OP0192 ADD-ON VS. REPLACEMENT csDMARD STRATEGIES POST-METHOTREXATE: A EUROPEAN ANALYSIS ON CSDMARD TREATMENT CHOICES2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Nils Steinz, D. Di Giuseppe, Tjardo Daniël Maarseveen, C.A. Hana, J. Sexton, C. Popescu, +7 more
0citations -
Exploring possibilities towards PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA): tailored modifications to standard treat-to-target management—a multicentre, randomised, open-label trial
Agnes E M Looijen, Hamit Harun Dağ, Judith W Heutz, Floris A van Gaalen, Mirjam C. Hegeman, Jos H van der Kaap, +10 more
0citations